Laurence Barker

Laurence Barker




Laurence is a Partner in the Dementia Discovery Fund (DDF) and has supported the funding and formation of numerous DDF companies developing transformational new medicines for dementia. He joined SV Health Investors in 2016 having played an active role in setting up DDF.

DDF Portfolio Board Roles

AstronauTx, AviadoBio, Cerevance, Endlyz and Therini Bio.

Prior to joining the DDF, Laurence was Head of Investment Management in Worldwide Business Development at GSK where he was responsible for managing GSK’s venture investment portfolio, covering both direct equity positions as well as a venture fund-of-funds portfolio. In addition, he led business development transactions for the pharma R&D business, including research collaborations, in- and out-licensing, asset acquisitions/divestitures and M&A. Prior to GSK, Laurence worked in business development at biotech companies Syntaxin and MorphoSys.

Academic Credentials
Laurence received his Masters degree in Biochemistry and Molecular Biology from the University of Auckland, New Zealand, his PhD in Biochemistry from the University of Tübingen, Germany, and an MBA from Cambridge, UK.

Executive Assistant
Tanya Finn

Portfolio Responsibility

Contact Tanya Finn

Fill in the form and Tanya will be in touch with you shortly.

Google reCaptcha: Invalid site key.

Why a form?
Your message is important to us so thank you for filling in our form – it will be received by the intended recipient and you will receive a reply via email. We’ve introduced a form to better protect our team from website scraping generated spam but hope that real people with real messages will still take the time to complete it.